Arthi Sridhar, M.D. - Faculty Profile

Biography

Arthi Sridhar, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. She specializes in the treatment of thoracic malignancies such as lung cancer, mesothelioma, and thymic tumors.

Dr. Sridhar earned her medical degree at M.S. Ramaiah Medical College in Bengaluru, India. She completed internal medicine residency training at UMass Chan Medical School - Baystate, where she served as Associate Chief Resident. She then gained advanced training through a hematology and medical oncology fellowship at McGovern Medical School at UTHealth Houston, where she was selected as Chief Hematology and Oncology Fellow. She also completed an advanced solid tumor oncology fellowship at the Mayo Clinic in Rochester, Minnesota.

Certified by the American Board of Internal Medicine in medical oncology, hematology, and internal medicine, Dr. Sridhar joined the UT Southwestern faculty in 2024.

Dr. Sridhar is a member of the International Association for the Study of Lung Cancer and the American Society of Clinical Oncology, where she is actively engaged in committees on volunteering.

She is involved in research related to immunotherapy, patient education, and improving healthcare outcomes, as well as studies related to lung cancer in younger patients. Dr. Sridhar has delivered presentations at national and international conferences and published multiple academic articles related to her areas of expertise.

Personal Note

When she’s not at work, Dr. Sridhar enjoys hiking, sampling different cuisines, and spending time with her family.

Education

Medical School: Rajiv Gandhi University of Health Sciences, India (2015)
Residency: UMass Chan Medical School - Baystate Medical Center (2020), Internal Medicine
Fellowship: University of Texas Health Science Center - McGovern Medical School (2023)
Fellowship: Mayo Clinic (2024), Thoracic Oncology

Research Interest

Lung Cancer Treatements

Publications

Featured Publications

Consolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.: Nassar AH, Jayakrishnan R, Feng J, Shepherd F, Adib E, Cheung JM, Lin JJ, Liu Y, Lin SH, Parikh K, Sridhar A, Shakya P, Dilling TJ, Kaldas D, Gray JE, Lobachov A, Bar J, Luders H, Grohe C, Gupta S, Leal T, Fitzgerald B, Crowley F, Fujiwara Y, Marron TU, Wilgucki M, Reuss J, Chen L, Sankar K, Aredo JV, Neal JW, Wakelee HA, Thummalapalli R, Yu H, Whitaker R, Velazquez A, Ragavan M, Cortellini A, Kwiatkowski DJ, Naqash AR, Goldberg SB, Kim SY, J Thorac Oncol 2025 Jan 20 1 109-118
Brief Report on Global Clinician Practices in the First-Line Management of Metastatic Non-Small Cell Lung Cancer.: Sridhar A, West HJ, Singhi EK, Clin Lung Cancer 2024 Nov 25 7 e286-e294
A Review of the Current Approach and Treatment Landscape for Stage III Non-Small Cell Lung Cancer.: Sridhar A, Khan H, Yohannan B, Chan KH, Kataria N, Jafri SH, J Clin Med 2024 Apr 13 9
Major Stressful Life Events and the Risk of Pancreatic, Head and Neck Cancers: A Case-Control Study.: Sridhar A, Sekhon VK, Nguyen C, Abushalha K, Tahanan A, Rahbar MH, Jafri SH, Cancers (Basel) 2024 Jan 16 2
Genomic profiling and sites of metastasis in non-small cell lung cancer.: Chan KH, Sridhar A, Lin JZ, Jafri SHR, Front Oncol 2023 13 1212788
Percutaneous dilatational tracheostomy. A safe, cost-effective bedside procedure.: Cobean R, Beals M, Moss C, Bredenberg CE, Arch Surg 1996 Mar 131 3 265-71

Honors & Awards

Chief Clinical Fellow
UTHealth Houston McGovern Medical School (2023)
Clerkship Director's Award for Outstanding Contribution to Medical Student Education
University of Massachusetts Chan Medical School (2020)
Jeff Crosby Patient Advocacy Award
University of Massachusetts Chan Medical School (2020)

Professional Associations/Affiliations

American Society of Clinical Oncology
American Society of Hematology
International Association for the Study of Lung Cancer